Cargando…
Dermatopathology of COVID-19 infection and vaccination
BACKGROUND: Many peculiar skin changes have been described in relation to both coronavirus disease 2019 (COVID-19) infection and vaccination. OBJECTIVE: This paper provides an overview of these dermatologic manifestations, focusing on their dermatopathological appearances. RESULTS: Most COVID-19 pat...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Medizin
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533285/ https://www.ncbi.nlm.nih.gov/pubmed/36197514 http://dx.doi.org/10.1007/s00292-022-01126-9 |
_version_ | 1784802311821852672 |
---|---|
author | Fernández-Figueras, María-Teresa |
author_facet | Fernández-Figueras, María-Teresa |
author_sort | Fernández-Figueras, María-Teresa |
collection | PubMed |
description | BACKGROUND: Many peculiar skin changes have been described in relation to both coronavirus disease 2019 (COVID-19) infection and vaccination. OBJECTIVE: This paper provides an overview of these dermatologic manifestations, focusing on their dermatopathological appearances. RESULTS: Most COVID-19 patients develop variegated maculopapular eruptions with a combination of histological patterns commonly including keratinocyte apoptosis and eosinophilia. Urticaria-like lesions often show a combination of spongiotic and lichenoid patterns and are more frequent in individuals with severe disease. Vesicular lesions can be disseminated; in some cases, they become pustular and in others show dyskeratosis and a peculiar form of ballooning. Some patients develop vesicular Grover disease on the trunk. Young patients with a strong immunological response can eliminate the virus easily but may develop chilblains as a consequence of the high interferon response. Conversely, older individuals with immunosenescence and a tendency toward hypercoagulability can present livedoid and ischemic areas. Regarding COVID-19 vaccination, hypersensitivity reactions are most frequent, including “COVID-arm.” Nonetheless, a combination of local and systemic cutaneous manifestations (reactogenicity) is commonly seen. Histopathologically, lichenoid and spongiotic changes and a variable number of eosinophils are typical of rashes characterized by papules and plaques. Other dermatological side effects of COVID-19 vaccination include lesions mimicking well-defined dermatoses such as lichen planus or bullous pemphigoid and triggering of collagenous diseases. CONCLUSION: Well-characterized skin manifestations of coronavirus disease 2019 (COVID-19) include chilblains, livedo necrotic lesions, vesicular eruptions, urticarial lesions, and maculopapular eruptions. Hypersensitivity reactions are common after SARS-CoV‑2 mRNA vaccination. Vaccine reactions may also mimic other dermatosis such as bullous pemphigoid or lichen planus, stimulate herpes reactivation, or trigger the development of autoimmune diseases. |
format | Online Article Text |
id | pubmed-9533285 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Medizin |
record_format | MEDLINE/PubMed |
spelling | pubmed-95332852022-10-05 Dermatopathology of COVID-19 infection and vaccination Fernández-Figueras, María-Teresa Pathologie (Heidelb) Hauptreferate: Hauptprogramm der DGP BACKGROUND: Many peculiar skin changes have been described in relation to both coronavirus disease 2019 (COVID-19) infection and vaccination. OBJECTIVE: This paper provides an overview of these dermatologic manifestations, focusing on their dermatopathological appearances. RESULTS: Most COVID-19 patients develop variegated maculopapular eruptions with a combination of histological patterns commonly including keratinocyte apoptosis and eosinophilia. Urticaria-like lesions often show a combination of spongiotic and lichenoid patterns and are more frequent in individuals with severe disease. Vesicular lesions can be disseminated; in some cases, they become pustular and in others show dyskeratosis and a peculiar form of ballooning. Some patients develop vesicular Grover disease on the trunk. Young patients with a strong immunological response can eliminate the virus easily but may develop chilblains as a consequence of the high interferon response. Conversely, older individuals with immunosenescence and a tendency toward hypercoagulability can present livedoid and ischemic areas. Regarding COVID-19 vaccination, hypersensitivity reactions are most frequent, including “COVID-arm.” Nonetheless, a combination of local and systemic cutaneous manifestations (reactogenicity) is commonly seen. Histopathologically, lichenoid and spongiotic changes and a variable number of eosinophils are typical of rashes characterized by papules and plaques. Other dermatological side effects of COVID-19 vaccination include lesions mimicking well-defined dermatoses such as lichen planus or bullous pemphigoid and triggering of collagenous diseases. CONCLUSION: Well-characterized skin manifestations of coronavirus disease 2019 (COVID-19) include chilblains, livedo necrotic lesions, vesicular eruptions, urticarial lesions, and maculopapular eruptions. Hypersensitivity reactions are common after SARS-CoV‑2 mRNA vaccination. Vaccine reactions may also mimic other dermatosis such as bullous pemphigoid or lichen planus, stimulate herpes reactivation, or trigger the development of autoimmune diseases. Springer Medizin 2022-10-05 2022 /pmc/articles/PMC9533285/ /pubmed/36197514 http://dx.doi.org/10.1007/s00292-022-01126-9 Text en © The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Hauptreferate: Hauptprogramm der DGP Fernández-Figueras, María-Teresa Dermatopathology of COVID-19 infection and vaccination |
title | Dermatopathology of COVID-19 infection and vaccination |
title_full | Dermatopathology of COVID-19 infection and vaccination |
title_fullStr | Dermatopathology of COVID-19 infection and vaccination |
title_full_unstemmed | Dermatopathology of COVID-19 infection and vaccination |
title_short | Dermatopathology of COVID-19 infection and vaccination |
title_sort | dermatopathology of covid-19 infection and vaccination |
topic | Hauptreferate: Hauptprogramm der DGP |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533285/ https://www.ncbi.nlm.nih.gov/pubmed/36197514 http://dx.doi.org/10.1007/s00292-022-01126-9 |
work_keys_str_mv | AT fernandezfiguerasmariateresa dermatopathologyofcovid19infectionandvaccination |